News
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Atrial fibrillation recurrence after catheter ablation was not significantly linked to major adverse outcomes, regardless of ...
18h
GlobalData on MSNFDA approves Element Science’s application for Jewel Patch defibrillatorThe US Food and Drug Administration (FDA) has approved Element Science’s premarket approval application for its Jewel Patch ...
Technological advancements in cardiac ablation, including improvements in catheter designs, ablation energy sources such as radiofrequency and cryoablation, and the introduction of innovative mapping ...
Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.
The Driver and Vehicle Licensing Agency has revealed the complete list of health conditions that drivers need to declare - ...
The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.
Rhythm Technologies (Nasdaq: IRTC) shares are on the rise on first-quarter results that were mixed compared to the Wall ...
In a registry of patients who underwent transcatheter aortic valve replacement, those who had single antiplatelet therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results